Parkevital, created in 1992 (Germany), from 1125 sister brands and 17477 competing brands. The Parkevital brand is owned by Pfizer Inc, a company listed in New York. Parkevital is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Pfizer Inc
(Parkevital)
over 5 years*
USD 16.95